Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra A Springer

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Drug and Alcohol Dependence|August 15, 2017
Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in UkraineRuthanne Marcus, Iuliia Makarenko, Alyona Mazhnaya, et al.
The Journal of Infectious Diseases|September 3, 2020
Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA's Advocacy AgendaSandra A Springer, Joshua A Barocas, Alysse Wurcel, et al.
Substance Use & Misuse|January 16, 2018
Prevalence, Diagnosis, and Treatment Rates of Mood Disorders among Opioid Users under Criminal Justice SupervisionMary Mbaba, Shan-Estelle Brown, Alese Wooditch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2018
Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized TrialSandra A Springer, Angela Di Paola, Marwan M Azar, et al.
AIDS and Behavior|November 9, 2011
Adherence to HIV treatment and care among previously homeless jail detaineesNadine E Chen, Jaimie P Meyer, Ann K Avery, et al.
AIDS Care|August 15, 2015
HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site studyPanagiotis Vagenas, Alexei Zelenev, Frederick L Altice, et al.
Journal of Substance Use and Addiction Treatment|May 12, 2024
Perspectives on benefits and risks of creation of an "injection drug use" billing codeGayathri Sundaram, Taisuke Sato, David Goodman-Meza, et al.
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|March 20, 2015
Prevalence and Predictors of Mental/Emotional Distress Among HIV+ Jail Detainees at Enrollment in an Observational StudyThomas Lincoln, Dominique Simon-Levine, JuliAnna Smith, et al.
AIDS and Behavior|May 16, 2013
Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jailEhsan Chitsaz, Jaimie P Meyer, Archana Krishnan, et al.
Contemporary Clinical Trials|April 10, 2021
Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorderNikhil Seval, Cynthia A Frank, Alain H Litwin, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Drug and Alcohol Dependence|August 15, 2017
Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in UkraineRuthanne Marcus, Iuliia Makarenko, Alyona Mazhnaya, et al.
The Journal of Infectious Diseases|September 3, 2020
Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA's Advocacy AgendaSandra A Springer, Joshua A Barocas, Alysse Wurcel, et al.
Substance Use & Misuse|January 16, 2018
Prevalence, Diagnosis, and Treatment Rates of Mood Disorders among Opioid Users under Criminal Justice SupervisionMary Mbaba, Shan-Estelle Brown, Alese Wooditch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2018
Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized TrialSandra A Springer, Angela Di Paola, Marwan M Azar, et al.
AIDS and Behavior|November 9, 2011
Adherence to HIV treatment and care among previously homeless jail detaineesNadine E Chen, Jaimie P Meyer, Ann K Avery, et al.
AIDS Care|August 15, 2015
HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site studyPanagiotis Vagenas, Alexei Zelenev, Frederick L Altice, et al.
Journal of Substance Use and Addiction Treatment|May 12, 2024
Perspectives on benefits and risks of creation of an "injection drug use" billing codeGayathri Sundaram, Taisuke Sato, David Goodman-Meza, et al.
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|March 20, 2015
Prevalence and Predictors of Mental/Emotional Distress Among HIV+ Jail Detainees at Enrollment in an Observational StudyThomas Lincoln, Dominique Simon-Levine, JuliAnna Smith, et al.
AIDS and Behavior|May 16, 2013
Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jailEhsan Chitsaz, Jaimie P Meyer, Archana Krishnan, et al.
Contemporary Clinical Trials|April 10, 2021
Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorderNikhil Seval, Cynthia A Frank, Alain H Litwin, et al.
Pageof 13